VeriMom¿Es hydrolyzed keratin pg-propyl methylsilanediol seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive toxicity for this ingredient or its parent components; no peer‑reviewed reports of developmental/reproductive toxicity located in the queried sources (PubMed, CIR, SCCS, ECHA, CosIng, PubChem, EWG). Keratin hydrolysates are large peptide fragments and the silanol-containing modifier lacks harmonised reproductive hazard (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, CosIng, PubChem, EWG).
Pregnancy-safe products containing hydrolyzed keratin pg-propyl methylsilanediol
Related ingredients
Frequently asked questions
- ¿Es hydrolyzed keratin pg-propyl methylsilanediol seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive toxicity for this ingredient or its parent components; no peer‑reviewed reports of developmental/reproductive toxicity located in the queried sources (PubMed, CIR, SCCS, ECHA, CosIng, PubChem, EWG). Keratin hydrolysates are large peptide fragments and the silanol-containing modifier lacks harmonised reproductive hazard (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, CosIng, PubChem, EWG).
- ¿Es hydrolyzed keratin pg-propyl methylsilanediol seguro durante la lactancia?
- No evidence from the prioritized sources of reproductive or lactation-specific toxicity, and no mechanism suggesting transfer into breastmilk identified in the available literature/databases. CIR/SCCS/ECHA do not list reproductive/lactation concerns for keratin hydrolysates or simple silanol propyl derivatives.
- ¿Es hydrolyzed keratin pg-propyl methylsilanediol seguro para la piel del bebé?
- Hazard and mechanism: no evidence of reproductive or developmental toxicity specific to infants in the searched sources. Exposure: increased exposure score (+1) relative to adults because infant skin has higher surface‑area‑to‑weight and an immature barrier; although the ingredient likely has limited systemic bioavailability (large peptide fraction and polar silanol moiety), measurable percutaneous absorption cannot be excluded for small modifier moieties so a conservative exposure increase for 0–3 yr is applied. Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, CosIng, PubChem, EWG.
- ¿Cómo puntúa VeriMom a hydrolyzed keratin pg-propyl methylsilanediol?
- VeriMom puntúa hydrolyzed keratin pg-propyl methylsilanediol en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a hydrolyzed keratin pg-propyl methylsilanediol en el embarazo?
- Consulta nuestra lista de alternativas seguras a hydrolyzed keratin pg-propyl methylsilanediol según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.